IMO the benefits of A2 protein only diary on digestive system offers A2M a competitive advantage in a market that the demographic may well have a greater propensity to seek out A2 platinum above others, although I'm no expert............there is no doubting A2M will remain a major player in the space and I suppose time will tell is the price ware & production glut will hit A2M hard...I assume that Super Alpha-Golden Stage Infant Formula will not be A2 protein only formula, if it is then OK, I need to reconsider holding A2M if not my view has not changed
A2M - 'Overweight' and 'Buy' rating from LightForce - 12 Month Target AUD 2.00/share, page-90
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.25 |
Change
0.510(8.89%) |
Mkt cap ! $4.525B | |||
| Open | High | Low | Value | Volume |
| $6.24 | $6.77 | $6.05 | $29.65M | 4.654M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 152106 | $6.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.00 | 370 | 1 |
View Market Depth
| Last trade - 11.20am 27/09/2024 (20 minute delay) ? |
| A2M (ASX) Chart |